Skip to content

Virtual Reality Pain Study

Virtual Reality as Nonpharmacologic Pain Management Among Hospitalized Inpatients. A Randomized Control Trial of Virtual Reality vs Standard of Care

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05293275
Acronym
VR Pain
Enrollment
100
Registered
2022-03-24
Start date
2022-03-15
Completion date
2023-10-31
Last updated
2022-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hospitalized Patients 18 Years of Age or Older With Pain

Brief summary

Investigating pain in hospitalized patients in two groups: virtual reality usage group vs standard of care

Detailed description

Patients will be randomized to either the virtual reality group or the standard of care group. The virtual reality group will use the device over two days. Both groups will answer questionnaires regarding their pain and anxiety. Medical records will be used to look at pain medication usage in both groups.

Interventions

DEVICEEaseVRx Virtual Reality Headset

Virtual reality device with 360 degree visualization of various scenery and interactive modules

Sponsors

Baylor Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* • patients at least 18 years of age, * reported pain in last 24 hours ≥ 3 on the Numerical Rating Scales (NRS), * patients undergoing surgery, * expected hospital length of stay of at least 48 hours, * English fluency, * willing to comply with study procedures. * Hx opioid use

Exclusion criteria

* • gross cognitive impairment that would interfere with the ability to consent or complete study procedures * current or prior diagnosis of epilepsy, seizure disorder, dementia, or migraines, * hypersensitivity to flashing light or motion, * history of motion sickness or cyber sickness, * medical condition predisposing to or current nausea, vomiting or dizziness, * stereoscopic vision or severe hearing impairment, * injury to eyes, face or neck that impedes comfortable use of virtual reality, * cancer related pain, * PHQ-9 screen indicating suicidal ideation, patients will be referred to appropriate clinical intervention (see suicide protocol) * currently pregnant, * current or recent completion of participation in any interventional pain study (with in past 2 months) * substance abuse (alcohol or illegal drugs): Alcohol- NIAAA definition of heavy drinking as more than 4 drinks on any day or more than 14 drinks per week for men, more than 3 drinks on any day or more than 7 drinks per week for women. Any illegal drugs including marijuana

Design outcomes

Primary

MeasureTime frameDescription
Pain assessed by Numerical Pain Rating Scale3-4 dayslevel of pain will be assessed using the Numerical Pain Rating Scale. The scale is composed of 0 (no pain) to 10 (worst pain imaginable)

Secondary

MeasureTime frameDescription
Anxiety assessed with numerical scale3-4 dayslevel of anxiety assessed with numerical scale composed of 0 (no anxiety) to 10 (anxiety out of control)
The PROMIS sleep disturbance questionnaire3-4 daysdisruption of sleep assessed using the PROMIS sleep disturbance questionnaire

Countries

United States

Contacts

Primary ContactMark Powers, PhD
mak.powers1@bswhealth.org5129936443

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026